Practitioner Information and Courses from MediaLab, Inc.
These are the MediaLab courses that cover Practitioner and links to relevant pages within the course.
Learn more about laboratory continuing education for medical technologists to earn CE credit for AMT, ASCP, NCA, and state license renewal and recertification. Or get information about laboratory safety and compliance courses that deliver cost-effective OSHA safety training and continuing education to your laboratory's employees.
| Monitored collection For monitored collections, the Department of Transportation classifies the following as health professionals: Physician Medical Technologist Medical Laboratory Technician Nurse (RN/LPN) Physician's Assistant/Nurse Practitioner Medical Technician (A medical technician is anyone who is licensed or certified to practice in the institution where the collection is being done. For example, a phlebotomist, EMT, or medical assistant.) | View Page |
| Postexposure prophlaxis Postexposure prophylaxis will be determined by exposure type and HIV infection status of source person. The postexposure prophylaxis determined by a qualified practitioner will balance risk of infection with toxicity of the medications.The postexposure prophylaxis must be started hours after the exposure.The postexposure prophylaxis should be re-evaluated 72 hours after exposure, particularly if additional information is available about source person.The postexposure prophylaxis may be necessary for 6 months. | View Page |
| The Board of Clinical Laboratory Personnel The Board of Clinical Laboratory Personnel oversees clinical laboratory affairs in the state of Florida. The Board's seven members are appointed by the Governor of Florida to serve four-year terms. Five of the seven members are licensed clinical laboratory practitioners and the remaining two, referred to as "consumer members," have never been licensed as clinical laboratory personnel and have no connection to the laboratory profession. The Board has the authority to: Establish rules for clinical laboratory science Set the necessary qualifications for clinical laboratory science personnel, including higher education, training programs, and examinations administered by the Board Oversee clinical laboratory training program and continuing education providers Issue licenses to clinical laboratory personnel Collect fees for licensing, license renewals, and delinquent licenses Enforce penalties, including license suspension and fines up to $10,000, for violations of Board rules governing ethics in clinical laboratory science | View Page |
| Penalties for violations Committing any violation listed on the prior pages carries severe penalties. An individual's clinical laboratory license can be put on probation or permanently revoked, and fines can range from $300 to $10,000 per offence. A license can also be put on probation, meaning the individual may continue to practice but under limited circumstances.
In addition, some violations listed in the previous pages carry criminal charges. These include:
Felonies (3rd degree)Practicing as clinical laboratory personnel without an active license Using a suspended or revoked license to practiceAttempting to obtain a license by misrepresentationMisdemeanors (1st degree)Concealing information relating to violations on the preceding pagesLying to the BoardMisrepresenting one's self as a licensed clinical laboratory practitioner | View Page |
| Which statement(s) are true? | View Page |
| Joint Commission Patient Safety Goals Joint Commission adopted national patient safety goals for healthcare organizations, including specific goals for laboratories. 2009 Laboratory Services National Patient Safety Goals These goals are directly quoted. | View Page |
| Advance Beneficiary Notice (ABN) An Advance Beneficiary Notice (ABNs) is given to a Medicare beneficiary to inform him/her (or that person's representative) that Medicare may not provide coverage in a specific case (e.g., for a specific laboratory test). Entities who issue ABNs are known as “notifiers.” "Notifiers" can include physicians, practitioners, laboratories, and other suppliers of services that are paid under Medicare Part B. The "notifier" (e.g., the laboratory) must complete the ABN and deliver the notice to the affected beneficiary or his/her representative before providing the items or services that are the subject of the notice. The ABN must be verbally reviewed with the beneficiary or his/her representative and any questions raised during that review must be answered before it is signed. The ABN must be delivered far enough in advance that the beneficiary or representative has time to consider the options and make an informed choice. Once all blanks are completed and the form is signed, a copy is given to the beneficiary or representative. In all cases, the notifier must retain the original notice on file. Note: ABNs are never required in emergency or urgent care situations. | View Page |
| Changes to ABN, Effective March 1, 2009 Beginning March 1, 2009, providers (including independent laboratories), physicians, practitioners, and suppliers are required to use a newly revised ABN form --Form CMS-R-131-- for all situations where Medicare payment is expected to be denied. The revised ABN replaces the existing General Use ABN, ABN-G (Form CMS-R-131G), and the Laboratory ABN, ABN-L (Form CMS-R-131L), and NEMB (Form CMS-20007). An example of the new form is included on this page as a resource. The revised form will continue to be used for notifying beneficiaries of Medicare denial reasons, but it may also be used to provide voluntary notification of financial liability. The revised ABN still permits pre-printing of lab-specific key information (blanks A - D) and still permits the use of the same denial reasons that were used with the former ABN-L (Blank E). Three commonly used reasons for noncoverage are: Medicare does not pay for this test for your condition. Medicare does not pay for this test as often as this (denied as too frequent). Medicare does not pay for experimental or research use tests. There must be at least one reason applicable to each item or service listed in Blank (D). The same reason for noncoverage may be applied to multiple items in Blank (D). | View Page |
| Label the morphologic structures on this parasite form: | View Page |
| A 31 year old male missionary worker recently returned from Africa where he helped a small rural community update their sanitation practices. He presented to his physician weak and complained of recent weight loss, abdominal pain, and diarrhea that was often bloody. The doctor ordered a battery of tests including a complete blood count (CBC) and stool for parasite examination. The CBC revealed eosinophilia and anemia. This suspicious form was seen on the wet preparations. It measured 52 µm by 27 µm. What parasite is mostly likely present? | View Page |
| A 17 year old female went to her doctor complaining of diarrhea. With the exception of seasonal allergies, she was in relatively good health. Patient history was unremarkable. A stool was submitted for culture and parasite examination. The culture was reported out as "no enteric pathogens isolated." This suspicious form was seen on wet preparation and permanent stain. It measures 27 µm. This patient is most likely suffering from which of the following conditions: | View Page |
| The artifact that when seen is indicative of intestinal inflammation and is characteristic of a number of parasitic infections is known as (a): | View Page |